CEMPRA INC's ticker is CEMP and the CUSIP is 15130J109. A total of 152 filers reported holding CEMPRA INC in Q3 2015. The put-call ratio across all filers is 0.66 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $75,320,000 | -88.8% | 26,900 | -2.9% | 0.01% | -88.0% |
| Q3 2016 | $670,340,000 | +45.7% | 27,700 | -0.7% | 0.12% | +46.2% |
| Q2 2016 | $460,071,000 | +1.0% | 27,900 | +7.3% | 0.08% | -5.9% |
| Q1 2016 | $455,520,000 | -43.7% | 26,000 | 0.0% | 0.08% | -38.8% |
| Q4 2015 | $809,380,000 | -57.4% | 26,000 | -61.9% | 0.14% | -44.2% |
| Q3 2015 | $1,900,080,000 | – | 68,250 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,193,060 | $68,270,000 | 11.77% |
| Abingworth LLP | 383,935 | $11,948,000 | 7.21% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $7,783,000 | 3.72% |
| Opaleye Management Inc. | 200,000 | $6,226,000 | 2.60% |
| Knoll Capital Management, LLC | 180,800 | $5,628,000 | 2.09% |
| Palo Alto Investors LP | 1,175,733 | $36,601,000 | 2.04% |
| BB BIOTECH AG | 1,991,900 | $62,008,000 | 1.75% |
| AlpInvest Partners B.V. | 31,400 | $977,000 | 1.62% |
| GENERAL AMERICAN INVESTORS CO INC | 494,409 | $15,391,000 | 1.41% |
| HARVEY CAPITAL MANAGEMENT INC | 112,250 | $3,494,000 | 1.38% |